Interaction of diabetes genetic risk and successful lifestyle modification in the Diabetes Prevention Programme.


Journal

Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645

Informations de publication

Date de publication:
04 2021
Historique:
revised: 20 12 2020
received: 23 09 2020
accepted: 23 12 2020
pubmed: 5 1 2021
medline: 10 7 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

To test whether diabetes genetic risk modifies the association of successful lifestyle changes with incident diabetes. We studied 823 individuals randomized to the intensive lifestyle intervention (ILS) arm of the Diabetes Prevention Programme who were diabetes-free 1 year after enrolment. We tested additive and multiplicative interactions of a 67-variant diabetes genetic risk score (GRS) with achievement of three ILS goals at 1 year (≥7% weight loss, ≥150 min/wk of moderate leisure-time physical activity, and/or a goal for self-reported total fat intake) on the primary outcome of incident diabetes over 3 years of follow-up. A lower GRS and achieving each or all three ILS goals were each associated with lower incidence of diabetes (all P < 0.05). Additive interactions were significant between the GRS and achievement of the weight loss goal (P < 0.001), physical activity goal (P = 0.02), and all three ILS goals (P < 0.001) for diabetes risk. Achievement of all three ILS goals was associated with 1.8 (95% CI 0.3, 3.4), 3.1 (95% CI 1.5, 4.7), and 3.9 (95% CI 1.6, 6.2) fewer diabetes cases/100-person-years in the first, second and third GRS tertiles (P < 0.001 for trend). Multiplicative interactions between the GRS and ILS goal achievement were significant for the diet goal (P < 0.001), but not for weight loss (P = 0.18) or physical activity (P = 0.62) goals. Genetic risk may identify high-risk subgroups for whom successful lifestyle modification is associated with greater absolute reduction in the risk of incident diabetes.

Identifiants

pubmed: 33394545
doi: 10.1111/dom.14309
pmc: PMC8852694
mid: NIHMS1776403
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1040

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK048412
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048375
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048434
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048413
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK116073
Pays : United States
Organisme : CSRD VA
ID : IK2 CX001907
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048468
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048387
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048404
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048437
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048407
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048397
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048381
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK111022
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048339
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048411
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048443
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048380
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048400
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048489
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK048349
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Diabetes Care. 2006 Sep;29(9):2102-7
pubmed: 16936160
Implement Sci. 2015 May 12;10:68
pubmed: 25962598
Diabetologia. 2014 Dec;57(12):2530-4
pubmed: 25273344
Diabetologia. 2015 Dec;58(12):2791-9
pubmed: 26416604
PLoS Med. 2014 May 20;11(5):e1001647
pubmed: 24845081
Am J Hum Genet. 2016 Jul 7;99(1):56-75
pubmed: 27321945
Diabetes Care. 2017 Dec;40(12):1668-1677
pubmed: 29021207
Diabetes. 2005 Aug;54(8):2404-14
pubmed: 16046308
Diabetes Care. 2015 Mar;38(3):439-44
pubmed: 25504030
Int J Obes (Lond). 2016 Jul;40(7):1164-9
pubmed: 27113490
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
N Engl J Med. 2008 Nov 20;359(21):2208-19
pubmed: 19020323
Nat Genet. 2012 Sep;44(9):991-1005
pubmed: 22885924
Diabet Med. 2013 Jan;30(1):3-15
pubmed: 22998334
Implement Sci. 2019 Aug 14;14(1):81
pubmed: 31412894
Med Sci Sports Exerc. 1997 Jun;29(6 Suppl):S1-205
pubmed: 9243481
Nat Genet. 2012 Sep;44(9):981-90
pubmed: 22885922
Diabetes. 2012 May;61(5):1291-6
pubmed: 22415877
Diabetes. 2012 Nov;61(11):3005-11
pubmed: 22891219
Diabetes. 2011 Apr;60(4):1340-8
pubmed: 21378175
Am J Prev Med. 2019 Mar;56(3):452-457
pubmed: 30661888
Diabetes. 2016 Feb;65(2):520-6
pubmed: 26525880
Implement Sci. 2015 Dec 15;10:172
pubmed: 26670418
Diabetes. 2014 Jun;63(6):2172-82
pubmed: 24520119
Circulation. 2011 Aug 2;124(5):563-71
pubmed: 21747052
Transl Behav Med. 2011 Sep;1(3):480-91
pubmed: 24073067
Health Aff (Millwood). 2012 Jan;31(1):67-75
pubmed: 22232096
JAMA Cardiol. 2018 Aug 1;3(8):693-702
pubmed: 29955826
Implement Sci. 2017 Jul 26;12(1):94
pubmed: 28747191
Am J Clin Nutr. 2016 Jul;104(1):198-204
pubmed: 27281308
Diabetes Care. 2017 Oct;40(10):1331-1341
pubmed: 28500215
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Am J Public Health. 2004 Oct;94(10):1736-42
pubmed: 15451743
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
JAMA. 2018 Feb 20;319(7):667-679
pubmed: 29466592
Ann Intern Med. 2020 Jan 7;172(1):35-45
pubmed: 31711134
Epidemiology. 2013 Jan;24(1):122-8
pubmed: 23222556
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
Am J Clin Nutr. 2012 Nov;96(5):1129-36
pubmed: 23034957
Circ Cardiovasc Genet. 2016 Dec;9(6):495-503
pubmed: 27784733
Diabetes Care. 1999 Apr;22(4):623-34
pubmed: 10189543
Ann Epidemiol. 1999 Jul;9(5):314-24
pubmed: 10976858
PLoS Genet. 2014 Aug 07;10(8):e1004517
pubmed: 25102180
Diabetes Care. 2013 Nov;36(11):3442-7
pubmed: 24009303
BMJ. 2015 Feb 19;350:h454
pubmed: 25697494
Diabetes Care. 2019 Apr;42(4):601-608
pubmed: 30877090

Auteurs

Sridharan Raghavan (S)

Medicine Service, Department of Veterans Affairs Eastern Colorado Healthcare System, Aurora, Colorado, USA.
Division of Hospital Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Colorado Cardiovascular Outcomes Research Consortium, Aurora, Colorado, USA.
Centre for Lifecourse Epidemiology of Adiposity and Diabetes, Colorado School of Public Health, Aurora, Colorado, USA.

Kathleen Jablonski (K)

Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.

Linda M Delahanty (LM)

Diabetes Unit and Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Nisa M Maruthur (NM)

Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Aaron Leong (A)

Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Paul W Franks (PW)

Department of Clinical Science, Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Malmö, Sweden.

William C Knowler (WC)

Diabetes Epidemiology and Clinical Research Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA.

Jose C Florez (JC)

Diabetes Unit and Endocrine Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Centre for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Programs in Metabolism and Medical & Population Genetics, Broad Institute, Cambridge, Massachusetts, USA.

Dana Dabelea (D)

Centre for Lifecourse Epidemiology of Adiposity and Diabetes, Colorado School of Public Health, Aurora, Colorado, USA.
Department of Epidemiology, Colorado School of Public Health, Aurora, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH